A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics

, &
Journal of Evaluation in Clinical Practice 12 (4):463-470 (2006)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2006.00731.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Costs and effectiveness of pre‐and post‐operative home physiotherapy for total knee replacement: randomized controlled trial.Caroline Mitchell, Jane Walker, Stephen Walters, Anne B. Morgan, Teena Binns & Nigel Mathers - 2005 - Journal of Evaluation in Clinical Practice 11 (3):283-292.
Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use.Nathalie Thilly, Serge Briancon, Yves Juilliere, Edith Dufay & Faiez Zannad - 2003 - Journal of Evaluation in Clinical Practice 9 (3):373-382.
Analytical decision model for sample size and effectiveness projections for use in planning a population‐based randomized controlled trial of colorectal cancer screening.Sherry Y.-H. Chiu, Nea Malila, Amy M.-F. Yen, Ahti Anttila, Matti Hakama & H.-H. Chen - 2011 - Journal of Evaluation in Clinical Practice 17 (1):123-129.
Electronic prescribing in an ambulatory care setting: a cluster randomized trial.Katie N. Dainty, Neill K. J. Adhikari, Alex Kiss, Sherman Quan & Merrick Zwarenstein - 2012 - Journal of Evaluation in Clinical Practice 18 (4):761-767.
An interactive education session and follow‐up support as a strategy to improve clinicians' goal‐writing skills: a randomized controlled trial.Elisabeth Marsland & Julia Bowman - 2010 - Journal of Evaluation in Clinical Practice 16 (1):3-13.
Cost‐effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT).Gregory P. Samsa PhD, David B. Matchar Md, G. Rhys Williams ScD & David E. Levy Md - 2002 - Journal of Evaluation in Clinical Practice 8 (1):61-70.
Shortcomings of the randomized controlled trial: a view from the boondocks.Joseph Herman Md - 1998 - Journal of Evaluation in Clinical Practice 4 (4):283-286.
Opinion of Japanese rheumatology physicians on methods of assessing the quality of rheumatoid arthritis care.Takahiro Higashi, Shunichi Fukuhara & Takeo Nakayama - 2012 - Journal of Evaluation in Clinical Practice 18 (2):290-295.
Effectiveness of nursing‐led inpatient care for patients with post‐acute health care needs: secondary data analysis from a programme of randomized controlled trials.Ruth Harris, Jenifer Wilson-Barnett & Peter Griffiths - 2007 - Journal of Evaluation in Clinical Practice 13 (2):198-205.
Medical technology assessment and the role of economic evaluation in health care.E. M. M. Adang, A. Ament & C. D. Dirksen - 1996 - Journal of Evaluation in Clinical Practice 2 (4):287-294.
Cluster randomized controlled trials.Suezann Puffer, David J. Torgerson & Judith Watson - 2005 - Journal of Evaluation in Clinical Practice 11 (5):479-483.
Exercise parameters in the treatment of clinical depression: a systematic review of randomized controlled trials.Luke G. Perraton, Saravana Kumar & Zuzana Machotka - 2010 - Journal of Evaluation in Clinical Practice 16 (3):597-604.
A review of cost‐effectiveness of varenicline and comparison of cost‐effectiveness of treatments for major smoking‐related morbidities. [REVIEW]Evelina A. Zimovetz, Koo Wilson, Miny Samuel & Stephen M. Beard - 2011 - Journal of Evaluation in Clinical Practice 17 (2):288-297.
Economic analysis for clinical practice – the case of 31 national consensus guidelines in the Netherlands.Louis W. Niessen, Els Grijseels, Marc Koopmanschap & Frans Rutten - 2007 - Journal of Evaluation in Clinical Practice 13 (1):68-78.
Comparison of the metabolic and economic consequences of long‐term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost‐effectiveness analysis.Roger S. McIntyre, Lael Cragin, Sonja Sorensen, Huseyin Naci, Tim Baker & Jean-Pascal Roussy - 2010 - Journal of Evaluation in Clinical Practice 16 (4):744-755.

Analytics

Added to PP
2013-11-24

Downloads
22 (#690,757)

6 months
5 (#629,136)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

No references found.

Add more references